Literature DB >> 34866598

Crystal structure of oligoribonuclease from Vibrio cholerae O1 El Tor with bound peptide.

Jianyu Zhang1, Liyuan Sun1, Qionglin Zhang1, Mark Bartlam1.   

Abstract

Oligoribonuclease (Orn), a member of the DEDDh superfamily, can hydrolyse 2-5 nt nanoRNAs to mononucleotides. It is involved in maintaining the intracellular levels of RNA, c-di-GMP signalling and transcription initiation in many bacterial species. Here, the crystal structure of Orn from Vibrio cholerae O1 El Tor (VcOrn) is reported at a resolution of 1.7 Å. VcOrn, which consists of nine α-helices and six β-strands, crystallizes with a single monomer in the asymmetric unit but forms a homodimer via crystallographic twofold symmetry. Electron density is observed in the active pocket that corresponds to an intersubunit N-terminal expression tag with sequence GPLGSHHH. The positively charged N-terminal tag binds in the negatively charged nucleotide-binding pocket with a buried surface area of ∼500 Å2. The N-terminal tag interacts with VcOrn via π-π stacking with two conserved residues involved in nucleotide binding, as well as via salt bridges and hydrogen bonds. The structure reported here reveals that the active pocket can accommodate polypeptides in addition to nucleotides, thus providing an important starting point for investigation into substrate modification and inhibitor design targeting VcOrn.

Entities:  

Keywords:  N-terminal tag; Vibrio cholerae; active pocket; crystal structure; oligoribonucleases

Mesh:

Substances:

Year:  2021        PMID: 34866598      PMCID: PMC8647215          DOI: 10.1107/S2053230X21011043

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  31 in total

1.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

2.  Structural genomics for drug design against the pathogen Coxiella burnetii.

Authors:  Matthew C Franklin; Jonah Cheung; Michael J Rudolph; Fiana Burshteyn; Michael Cassidy; Ebony Gary; Brandan Hillerich; Zhong-Ke Yao; Paul R Carlier; Maxim Totrov; James D Love
Journal:  Proteins       Date:  2015-10-06

Review 3.  The special existences: nanoRNA and nanoRNase.

Authors:  Hebin Liao; Mafeng Liu; Xiaolan Guo
Journal:  Microbiol Res       Date:  2017-11-29       Impact factor: 5.415

4.  Purification and crystallization of Bacillus subtilis NrnA, a novel enzyme involved in nanoRNA degradation.

Authors:  Claudiu M Nelersa; Brad J Schmier; Arun Malhotra
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-29

Review 5.  Cyclic di-GMP: second messenger extraordinaire.

Authors:  Urs Jenal; Alberto Reinders; Christian Lori
Journal:  Nat Rev Microbiol       Date:  2017-02-06       Impact factor: 60.633

Review 6.  Cyclic di-GMP: the first 25 years of a universal bacterial second messenger.

Authors:  Ute Römling; Michael Y Galperin; Mark Gomelsky
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

7.  A dedicated diribonucleotidase resolves a key bottleneck for the terminal step of RNA degradation.

Authors:  Soo-Kyoung Kim; Justin D Lormand; Cordelia A Weiss; Karin A Eger; Husan Turdiev; Asan Turdiev; Wade C Winkler; Holger Sondermann; Vincent T Lee
Journal:  Elife       Date:  2019-06-21       Impact factor: 8.140

8.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

9.  Degradation of nanoRNA is performed by multiple redundant RNases in Bacillus subtilis.

Authors:  Ming Fang; Wencke-Maria Zeisberg; Ciaran Condon; Vasily Ogryzko; Antoine Danchin; Undine Mechold
Journal:  Nucleic Acids Res       Date:  2009-06-24       Impact factor: 16.971

10.  Dinucleotide Degradation by REXO2 Maintains Promoter Specificity in Mammalian Mitochondria.

Authors:  Thomas J Nicholls; Henrik Spåhr; Shan Jiang; Stefan J Siira; Camilla Koolmeister; Sushma Sharma; Johanna H K Kauppila; Min Jiang; Volkhard Kaever; Oliver Rackham; Andrei Chabes; Maria Falkenberg; Aleksandra Filipovska; Nils-Göran Larsson; Claes M Gustafsson
Journal:  Mol Cell       Date:  2019-10-03       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.